• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
    • Dr. Prescott’s Columns
  • Patients
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for rights

rights

OMRF enters into a license agreement with Shanghai RAAS Blood Products

February 13, 2018

OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.

Filed Under: News, Technology Ventures News Tagged With: Activated Protein C, agreement, americans, antibody, apc, approval, blood, blood clots, breakthrough, CDC, Charles, charles esmon, China, chuck esmon, deal, death, disorder, drug, Esmon, forbes, hemophilia, injuries, innovation, license, Manu Nair, new, news, newsok, novel, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, products, research, rights, scientist-news, sepsis, shanghai raas, technology, trauma, traumatic bleeding, treatment

Q BioMed Inc. finalizes license agreement with OMRF, RGCB

June 15, 2017

QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.

Filed Under: News, Technology Ventures News Tagged With: agreement, cancer, cells, chemo, denis corin, develop, drug, license, liver cancer, medical, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, otcqb, q biomed, qbio, rajiv gandhi centre for biotechnology, research, rgcb, Rheal, rheal towner, rights, scientist-news, therapy, Towner, uttrocide b

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In